- Recent Funding
- Investors
- Michigan Accelerator Fund I
Michigan Accelerator Fund I portfolio
Michigan Accelerator Fund I has 1 portfolio company on record at Recent Funding.
About this page
It led 1 of the 2 rounds it joined. Its most recent investment on record is Ablative Solutions's $77M Series B+ round in January 2019, alongside Gilde Healthcare and BioStar Capital. That company is in Health and bio. It has co-invested with BioStar Capital and Gilde Healthcare, most often BioStar Capital (2 rounds).
What Michigan Accelerator Fund I invests in
- Health and bio · 1 · 100%
How Michigan Accelerator Fund I invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 2 100% | $77M |
| Year | Deals | Capital in rounds |
|---|---|---|
| 2014 | 1 50% | undisclosed |
| 2019 | 1 50% | $77M |
Michigan Accelerator Fund I portfolio companies
AAblative Solutions$77MSeries B+ · Jan 2019
| Company | Round with Michigan Accelerator Fund I | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $77M | $159.3M | Jun 13, 2022 Series B+ |
Most frequent co-investors
BBioStar Capital2 shared rounds · last Jan 3, 2019
GGilde Healthcare1 shared round · last Jan 3, 2019
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 2 rounds on Recent Funding that name Michigan Accelerator Fund I. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Michigan Accelerator Fund I, which is a subset of its real portfolio. API: /api/v1/investors/michigan-accelerator-fund-i (get a free API key). More: the most active VC firms and new venture capital funds.